1. Home
  2. AFRM vs DGX Comparison

AFRM vs DGX Comparison

Compare AFRM & DGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Affirm Holdings Inc.

AFRM

Affirm Holdings Inc.

HOLD

Current Price

$70.98

Market Cap

28.3B

ML Signal

HOLD

Logo Quest Diagnostics Incorporated

DGX

Quest Diagnostics Incorporated

HOLD

Current Price

$227.07

Market Cap

23.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AFRM
DGX
Founded
2012
1967
Country
United States
United States
Employees
N/A
N/A
Industry
Business Services
Medical Specialities
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
28.3B
23.2B
IPO Year
2020
1996

Fundamental Metrics

Financial Performance
Metric
AFRM
DGX
Price
$70.98
$227.07
Analyst Decision
Buy
Buy
Analyst Count
25
13
Target Price
$84.52
$214.38
AVG Volume (30 Days)
3.7M
928.9K
Earning Date
05-07-2026
04-21-2026
Dividend Yield
N/A
1.82%
EPS Growth
108.98
13.78
EPS
0.90
2.24
Revenue
$3,224,412,000.00
$11,035,000,000.00
Revenue This Year
$30.78
$7.53
Revenue Next Year
$23.95
$3.77
P/E Ratio
$79.12
$101.73
Revenue Growth
38.80
11.78
52 Week Low
$42.10
$165.78
52 Week High
$100.00
$237.78

Technical Indicators

Market Signals
Indicator
AFRM
DGX
Relative Strength Index (RSI) 40.29 69.99
Support Level $66.21 $186.40
Resistance Level $79.10 N/A
Average True Range (ATR) 3.08 5.18
MACD -1.69 0.62
Stochastic Oscillator 2.29 86.79

Price Performance

Historical Comparison
AFRM
DGX

About AFRM Affirm Holdings Inc.

Founded in 2012, Affirm is a market leader in the buy now, pay later space with around $36 billion in transaction volume in fiscal 2025. Affirm offers both zero-interest financing, which is merchant subsidized, and interest-bearing loans, which function as personal loans that are approved on a per-transaction basis. Over 70% of Affirm's transaction volume comes from its interest-bearing loans, which also constitute the majority of its revenue. Affirm primarily operates in the United States, which accounted for more than 95% of its revenue in 2025, but it has also expanded to Canada and the United Kingdom.

About DGX Quest Diagnostics Incorporated

Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the US. The company generates over 97% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,400 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.

Share on Social Networks: